Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: Pro 2018-026
Bond Short Name: 13 Jianfeng 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
on the acquisition of the "Drug GMP Certificate" by the holding subsidiary
The board of directors and all directors of the company guarantee this announcement There are no false records, misleading statements or major omissions, and they are individually and jointly liable for the authenticity, accuracy and completeness of their contents.
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical") received Zhejiang Food The "Drug GMP Certificate" issued by the Drug Administration. The relevant information is hereby announced as follows:
1. GMP Certification Related Information
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.
Address: No.
Certificate No.: No. 368 Jinqu Road, Jinhua Industrial Park, Zhejiang Province: ZJ20180081
Certification Scope: Eye Drops, Ear Drops
Valid: august 2, 2023
2. involves production line capacity and main products:
Production Line Name |
Design Annual Capacity |
Variety |
Eye Drops Production Line |
Million |
Sodium Hyaluronate Eye Drops |
Ear Drops Production Line |
.5 Million |
Ofloxacin Ear Drops |
Market Situation of Main Products of 3. Company
Drug Name |
Dosage Form |
functional indications |
main manufacturer |
sodium hyaluronate eye drops |
eye drops |
are used for Sjogren's syndrome, Sjogren's syndrome, xerophthalmia |
towering pharmaceutical (China) co., ltd ; Qilu Pharmaceutical Co., Ltd.; Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch; |
Ofloxacin Ear Drops |
Ear Drops |
is used to treat otitis media, otitis externa and tympanitis caused by sensitive bacteria |
Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd; Nanjing Tianlang Pharmaceutical Co., Ltd.; Wuhan Wujing Pharmaceutical Co., Ltd.; |
Note: 1. The information of "Main Manufacturers" in the fourth column of the table mainly comes from the website of china food and drug administration.
2, 2017, peak pharmaceutical sodium hyaluronate eye drops sales revenue of 15.9176 million yuan, the sales revenue of ofloxacin ear drops was 1.2665 million yuan.
Impact of 4. on Listed Companies and Risk Tips
The "Drug GMP Certificate" obtained by Jianfeng Pharmaceutical this time is not the certification certificate of the new production line, but the certificate obtained after the GMP certificate of its original eye drop and ear drop production line expires and is re-certified. Obtaining the GMP certificate again will help ensure the product quality and production capacity of Jianfeng Pharmaceutical, ensure market supply, and will not have a significant impact on the company's current operations. The specific future sales of various drugs of
Company may be affected by market environment, industry policy, supply and demand relationship and other factors, with uncertainty. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
August 14, 2018
More information
The company organized "charity one day donation"
On the morning of October 22, in the lobby on the first floor of Jianfeng Building, all cadres and employees of the group headquarters and subordinate enterprises working in Jianfeng Building participated in the 2021 "Charity Day Donation" activity to offer their love to Jinhua charity. In the next few days, the company's subordinate enterprises also organized "charity one-day donation" activities one after another.
2021
11-01
The company organizes new employee induction training
"Growth is more important than success. I hope everyone can become the backbone and pillars of the peak as soon as possible." On September 2, Yu Jianhong, general manager of the group company, put forward ardent hopes in the face of new employees. On the 2nd and 3rd, the group company organized induction training for new employees recruited in the past year. The group company chairman Jiang Xiaomeng, general manager Yu Jianhong and other leaders and relevant department heads gave lectures to them.
2021
09-13
Daye Peak: Typical Regional Industrial Green Development
On August 23, Huangshi Radio and Television Station broadcast the special program of "Strengthening Overall Planning and Promoting Energy Saving and Emission Reduction in Industrial Field". Daye Jianfeng Cement Company, as a typical enterprise with outstanding achievements in establishing green factories and energy saving and emission reduction in Huangshi area, appeared in the program.
2021
09-01
Yunnan Peak Helps Border Epidemic Prevention and Control
On August 22, Yunnan Peak Cement Company, through the Red Cross Society of Pu'er City and the Epidemic Prevention Headquarters of Pu'er City, donated vacuum insulation pots with a total value of 800000 yuan to the four border counties for the prevention and control of the new coronary pneumonia epidemic in the border area, and supported the prevention and control of the epidemic at the border with practical actions.
2021
09-01
Group Party Committee to Learn "July 1" Important Speech
On August 13, the party committee of the group company held a special meeting to collectively study General Secretary Xi Jinping's important speech at the celebration meeting of the 100 anniversary of the founding of the Communist Party of China, convey the requirements of the party committee at a higher level, and make arrangements for organizing party members of the company to study the "July 1" speech.
2021
08-23
Spike Ranked 2020 China's Top 100 Cement Clinker Production Capacity
Recently, the company received the "2020 China Cement Clinker Production Capacity Top 100" plaque issued by China Cement Network. The ranking of China's top 100 cement clinker production capacity is organized and evaluated by China Cement Network, an authoritative information platform for the domestic cement industry. It is released according to the actual clinker production capacity of each cement enterprise at the end of last year. The company has been ranked in the top 100 list for many consecutive years.
2021
08-23